Abiomed's Heart Pump Can Improve Outcomes in Some Patients

The use of Abiomed's (NASDAQ:ABMD) Impella heart pumps reduced the rate of death, stroke, myocardial infarction, and repeat procedures in high-risk percutaneous coronary intervention (PCI) patients, according to a new study.